This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
🎯 Background & Rationale
Interventional pulmonology (IP) has evolved rapidly over recent decades, becoming a cornerstone of multidisciplinary thoracic care globally. However, its distribution remains profoundly unequal. While high-income countries rapidly adopt advanced technologies like robotic bronchoscopy and navigational platforms, many low- and middle-income regions struggle to maintain basic flexible bronchoscopy. Africa faces a particularly heavy and unique burden of respiratory disease—driven by a dual epidemic of tuberculosis and a rising incidence of lung cancer—yet a continental perspective on IP capacity, training pathways, and structural barriers had been entirely lacking. This study aimed to map the current landscape of IP across Africa to generate the evidence base required for advocacy, policy development, and targeted infrastructure investment.
👥 Study Design & Population
Study Type: Cross-sectional descriptive survey (observational practice survey).
- Population: 51 interventional pulmonologists practicing across 16 African countries, representing all 5 African subregions (Northern, Western, Eastern, Central, and Southern Africa).
- Participant Profile: Characterized by significant professional seniority, with 60.8% of participants reporting 15 or more years of experience in respiratory medicine.
📈 Methodology & Rigor
- Data Collection: Utilized a structured, web-based questionnaire (Google Forms) comprising 26 items across 6 domains (demographics, institutional IP capacity, national-level IP landscape, access/reimbursement/registries, training, and barriers/perceived demand). The survey underwent iterative development, content-validity review by co-authors spanning all 5 subregions, and pilot testing.
- Statistical Analysis: Descriptive statistical analysis reporting absolute numbers ($n$) and percentages (%) for categorical variables. Cross-tabulations were used to explore geographic relationships and institutional capacities. Formal hypothesis testing was not performed due to the descriptive, non-probabilistic convenience sampling method. Missing data were managed via pairwise deletion.
🔬 Key Findings [or Planned Endpoints]
- Institutional Capacity & Regional Divide: 49.0% of respondents reported a dedicated IP unit at their institution, but this was heavily skewed: 75.0% in Northern Africa and 100% in Southern Africa (South Africa), versus 12.5% in Eastern Africa and 0.0% in Central Africa. Overall, 62.7% of respondents’ patients could access an IP unit either on-site or via referral.
- Techniques Available: Among functional IP units, medical thoracoscopy (80.0%) and therapeutic rigid bronchoscopy (80.0%) predominated, followed by transbronchial cryobiopsy (64.0%), linear EBUS (52.0%), and APC/laser (52.0%). Radial EBUS (24.0%) and navigation systems (4.0%) were rare, while cone-beam CT, valve/vapor therapies, and robotic bronchoscopy were completely absent (0%).
- Training Gaps: 49.0% of respondents had no structured IP training, relying entirely on self-taught learning/workshops. Among the 51% with structured training, 84.6% trained outside of Africa. Furthermore, 62.7% of respondents rated junior doctor training in IP as “insufficient” or “non-existent.”
- Barriers & Demand: Primary barriers cited were lack of equipment (56.0%), high equipment/procedure costs (40.0%), lack of institutional support (36.0%), and lack of training (36.0%). Despite these barriers, 98% of respondents rated local demand as “medium” to “very high.” Only 6.1% of respondents reported full reimbursement for IP procedures, and national registries existed in only 6.1% of responses.
⚖️ Critical Appraisal
- Internal/External Validity & Biases: The study provides a valuable first-of-its-kind continental snapshot, but it carries inherent methodological limitations. The lack of an existing continental or national registry prevented the calculation of a true response rate.
- Representativeness: Convenience sampling and asymmetric geographic representation (47.1% from Northern Africa vs. 9.8% from Central and 3.9% from Southern Africa) mean continent-wide figures are heavily weighted toward Northern Africa. Subregional findings for Central and Southern Africa represent preliminary, exploratory signals.
- Generalizability: While individual-level data (training, barriers) remain valid at the respondent level, institutional capacities cannot be generalized uniformly across entire sub-Saharan nations without local registry confirmation.
💡 The Clinical Bottom Line
Interventional pulmonology in Africa is not a luxury subspecialty but an essential service facing a severe capacity and training gap that fails to reach the majority of the population. Bridging this gap requires moving away from extremely high-cost Western technologies (such as robotics) and instead prioritizing high-yield, cost-effective innovations suited for resource-limited settings—specifically EBUS-TBNA and transbronchial cryobiopsy. Sustainable development will depend on establishing indigenous regional training hubs (such as the WABIP Institute in Nairobi), reforming universal health coverage reimbursement policies to include IP codes, and creating national/continental procedure registries to drive evidence-based advocacy.
Abstract
Keep reading
N opens the next oneClinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
CT-guided fiducial placement remains a relevant technique for pre-procedural localization of peripheral lung lesions.
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.